Evidence map›Paper›PMID 33603618›Full record

ArticlePostepy dermatologii i alergologii2020

Differentiation of skin biopsies by light scattering spectroscopy.

Tuba Denkçeken, Fatma Elif Yıldırım, Cihan Atak, Mehmet Sökücü

Open access · goldAbstract read
In one paragraph

Article in Postepy dermatologii i alergologii, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 100% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Tuba DenkçekenDepartment of Biophysics, Faculty of Medicine, SANKO University, Gaziantep, Turkey.
Fatma Elif YıldırımDepartment of Dermatology and Venereology, Faculty of Medicine, SANKO University, Gaziantep, Turkey.
Cihan AtakDepartment of Biophysics, Faculty of Medicine, SANKO University, Gaziantep, Turkey.
Mehmet SökücüDepartment of Pathology, Faculty of Medicine, SANKO University, Gaziantep, Turkey.
Sanko University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSpectroscopic systems are medical tools that are used for the detection of cancerous tissues

aimTo differentiate inflammatory and benign skin lesions of excised biopsy samples via a combination of multivariate statistical analysis. MATERIAL AND

methodsSpectral data were obtained from a total of 22 inflammatory and ten benign skin biopsy samples from 30 patients in the visible wavelength (450-750 nm) regions. Spectral data were compared with the dermatopathology results. Spectral data analyses of biopsy samples were performed via principal component analysis (PCA), followed by linear discriminant analysis (LDA). The differentiation performance was calculated with the receiver operating characteristic (ROC) curve analysis.

resultsThe classification based on the discriminant function score provided a sensitivity of 90.9% and a specificity of 80% in discriminating benign from inflammatory lesions with an accuracy of 87.5%.

conclusionsOur study revealed that light scattering spectroscopy could discriminate between inflammatory and benign skin lesions of excised biopsy samples with high sensitivity by using multivariate statistical analysis. It can be concluded that the high diagnostic accuracy of the optical spectroscopy method has the potential to use as a supplementary system to distinguish inflammatory skin lesions from benign during the pathological examination.

Indexed as

inflammatorylinear discriminantprincipal componentskinspectroscopy

Identifiers

PMID33603618
PMCPMC7874857
OpenAlexW3003586198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.